i am searching for the companies that i like that can thrive in this environment with the fiscal cliff and with a recession a possibility. look, it's a possibility if they don't solve this thing. today i was throwing a surprise party for amgen. you know what, fiscal cliff, no fiscal cliff, we're still having an amgen party here. inappropriate balloon moment there. they make all kinds of drugs for many serious illnesses. it has seven products in development that are starting phase three clinical trials in the early part of next year. phase three means it's getting near fruition. amgen could double earnings per share over the next eight years. that is much better than a sharp stick in the retina. amgen reported on october 23rd after the close and the company delivered spectacular results and was a true triple play. earnings came in $1.67, and revenues 5.9% year over year. when the street was looking for $4.25 billion. management's four-year guidance, substantially higher than the analysts expecting. those were fabulous numbers. no surprise that the stock shot up from $87.32, to nearly $9